The effect of current therapeutic modalities on epithelial barrier defects and remodelling

O. Yilmaz (Izmir, Turkey)

Source: International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases
Disease area: Paediatric lung diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Yilmaz (Izmir, Turkey). The effect of current therapeutic modalities on epithelial barrier defects and remodelling. International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CFTR dysfunction and its relationship to phenotype and development of new treatments restoring CFTR function
Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Year: 2013

The effect of age on lung epithelial barrier function
Source: International Congress 2018 – Intercellular communication in tissue remodelling
Year: 2018



Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Corticosteroids improve airway epithelial regeneration and restore oxidative stress-induced epithelial barrier dysfunction
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012



Beneficial effects of HDAC6 inhibition on airway epithelial barrier function
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


The roles of PCDH1 on epithelial barrier function in the airway
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012

Growth factor treatment for asthma by restoration of epithelial barrier function
Source: Annual Congress 2008 - New treatments for asthma
Year: 2008

The role of altered stem cell function in airway and alveolar repair and remodelling in COPD
Source: Eur Respir Monogr 2021; 91: 322-339
Year: 2021


Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017



A novel strategy to counteract airway wall remodelling in asthma: blocking the neo-vascularisation of the lamina propria
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Modeling the regenerative potential of airway epithelial cells
Source: Virtual Congress 2020 – (Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration
Year: 2020


TGFβ1 induced loss of β-adrenergic response in human bronchial smooth muscle cells (hBSMC) is dependent on TGFβ-RI kinase activity: potential therapeutic application in treating airway diseases
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


A 3D tissue-engineered airway model for the assessment of epithelial responses to novel nanotherapeutics
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Human rhinovirus causes increase in angiogenetic activity of lung endothelial cells – potential involvement in enhanced vasculature in asthmatics
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021

Role of microRNAs in regulation of T17-driven airway epithelial barrier dysfunction
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020


ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020
Year: 2020



The in vitro effect of corticosteroids on components of airway remodeling
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010